Nitric oxide nanoparticles

References

• Olson DP, Soares S, Kanade SV. Community-acquired MRSA pyomyositis: case report and review of the literature. J Trop Med 2011; 2011:970848; PMID: 21461362
   PubMedGoogle Scholar
• Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO Jr., Kaplan SL. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006; 43:953 - 60; http://dx.doi.org/10.1086/507637; PMID: 16983604
   PubMed Web of Science ®Google Scholar
• Boucher HW. Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication. Clin Infect Dis 2010; 50:Suppl 1 S4 - 9; http://dx.doi.org/10.1086/647937; PMID: 20067391
   PubMed Web of Science ®Google Scholar
• Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:155 - 64; http://dx.doi.org/10.1086/524891; PMID: 18171244
   PubMed Web of Science ®Google Scholar
• Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99:2818 - 25; http://dx.doi.org/10.1172/JCI119473; PMID: 9185502
   PubMed Web of Science ®Google Scholar
• Han G, Zippin JH, Friedman A. From Bench to Bedside: The Therapeutic Potential of Nitric Oxide in Dermatology. J Drugs Dermatol 2009; 8:586 - 94; PMID: 19537386
   PubMed Web of Science ®Google Scholar
• Jones ML, Ganopolsky JG, Labbe A, Prakash S. A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: preparation and in vitro analysis. Appl Microbiol Biotechnol 2010; 87:509 - 16; http://dx.doi.org/10.1007/s00253-010-2490-x; PMID: 20300748
   PubMed Web of Science ®Google Scholar
• Seabra AB, Martins D, Simoes M, da Silva R, Brocchi M, de Oliveira MG. Antibacterial nitric oxide-releasing polyester for the coating of blood-contacting artificial materials. Artif Organs 2010; 34:E204 - 14; http://dx.doi.org/10.1111/j.1525-1594.2010.00998.x; PMID: 20497163
   PubMedGoogle Scholar
• Major TA, Panmanee W, Mortensen JE, Gray LD, Hoglen N, Hassett DJ. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob Agents Chemother 2010; 54:4671 - 7; http://dx.doi.org/10.1128/AAC.00379-10; PMID: 20696868
   PubMed Web of Science ®Google Scholar
• Mihu MR, Sandkovsky U, Han G, Friedman JM, Nosanchuk JD, Martinez LR. The use of nitric oxide releasing nanoparticles as a treatment against Acinetobacter baumannii in wound infections. Virulence 2010; 1:62 - 7; http://dx.doi.org/10.4161/viru.1.2.10038; PMID: 21178416
   PubMed Web of Science ®Google Scholar
• Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials 2009; 30:2782 - 9; http://dx.doi.org/10.1016/j.biomaterials.2009.01.052; PMID: 19233464
   PubMed Web of Science ®Google Scholar
• Martinez LR, Han G, Chacko M, Mihu MR, Jacobson M, Gialanella P, et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against staphylococcus aureus skin infection. J Invest Dermatol 2009; 129:2463 - 9; http://dx.doi.org/10.1038/jid.2009.95; PMID: 19387479
   PubMed Web of Science ®Google Scholar
• Hetrick EM, Shin JH, Stasko NA, Johnson CB, Wespe DA, Holmuhamedov E, et al. Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano 2008; 2:235 - 46; http://dx.doi.org/10.1021/nn700191f; PMID: 19206623
   PubMed Web of Science ®Google Scholar
• Friedman A, Friedman J. New biomaterials for the sustained release of nitric oxide: past, present and future. Expert Opin Drug Deliv 2009; 6:1113 - 22; http://dx.doi.org/10.1517/17425240903196743; PMID: 19663720
   PubMed Web of Science ®Google Scholar
• Friedman AJ, Han G, Navati MS, Chacko M, Gunther L, Alfieri A, et al. Sustained release nitric oxide releasing nanoparticles: Characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008; 19:12 - 20; http://dx.doi.org/10.1016/j.niox.2008.04.003; PMID: 18457680
   PubMed Web of Science ®Google Scholar
• Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, et al. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation 2001; 104:2338 - 43; http://dx.doi.org/10.1161/hc4401.098432; PMID: 11696475
   PubMed Web of Science ®Google Scholar
• Friedman A, Blecher K, Sanchez D, Tuckman-Vernon C, Gialanella P, Friedman JM, et al. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence 2011; 2:217 - 21; http://dx.doi.org/10.4161/viru.2.3.16161; PMID: 21577055
   PubMed Web of Science ®Google Scholar
• Han G, Martinez LR, Mihu MR, Friedman AJ, Friedman JM, Nosanchuk JD. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS ONE 2009; 4:e7804; http://dx.doi.org/10.1371/journal.pone.0007804; PMID: 19915659
   PubMed Web of Science ®Google Scholar
• Han G, Friedman AJ, Friedman JM. Nitric oxide releasing nanoparticle synthesis and characterization. Methods Mol Biol 2011; 704:187 - 95; http://dx.doi.org/10.1007/978-1-61737-964-2_14; PMID: 21161638
   PubMedGoogle Scholar
• Fernandez J, Hilliard JJ, Abbanat D, Zhang W, Melton JL, Santoro CM, et al. In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother 2010; 54:116 - 25; http://dx.doi.org/10.1128/AAC.00642-09; PMID: 19884364
   PubMed Web of Science ®Google Scholar
• Patel MV, De Souza NJ, Gupte SV, Jafri MA, Bhagwat SS, Chugh Y, et al. Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models. Antimicrob Agents Chemother 2004; 48:4754 - 61; http://dx.doi.org/10.1128/AAC.48.12.4754-4761.2004; PMID: 15561853
   PubMed Web of Science ®Google Scholar
• Tavares AF, Nobre LS, Melo AM, Saraiva LM. A novel nitroreductase of Staphylococcus aureus with S-nitrosoglutathione reductase activity. J Bacteriol 2009; 191:3403 - 6; http://dx.doi.org/10.1128/JB.00022-09; PMID: 19286809
   PubMed Web of Science ®Google Scholar
• Farokhzad OC. Nanotechnology for drug delivery: the perfect partnership. Expert Opin Drug Deliv 2008; 5:927 - 9; http://dx.doi.org/10.1517/17425247.5.9.927; PMID: 18754745
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009; 3:16 - 20; http://dx.doi.org/10.1021/nn900002m; PMID: 19206243
   PubMed Web of Science ®Google Scholar
• Friedman A, Friedman J. New biomaterials for the sustained release of nitric oxide: past, present and future. Expert Opin Drug Deliv 2009; 6:1113 - 22; http://dx.doi.org/10.1517/17425240903196743; PMID: 19663720
   PubMed Web of Science ®Google Scholar
• Griffith RS. Introduction to vancomycin. Rev Infect Dis 1981; 3:Suppl S200 - 4; PMID: 7043707
   PubMedGoogle Scholar
• Mowbray M, Tan X, Wheatley PS, Rossi AG, Morris RE, Weller RB. Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. J Invest Dermatol 2008; 128:352 - 60; http://dx.doi.org/10.1038/sj.jid.5701096; PMID: 17914444
   PubMed Web of Science ®Google Scholar
• Dal Secco D, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha Fde Q. Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 2003; 9:153 - 64; http://dx.doi.org/10.1016/j.niox.2003.11.001; PMID: 14732339
   PubMed Web of Science ®Google Scholar
• Breen JO. Skin and soft tissue infections in immunocompetent patients. Am Fam Physician 2010; 81:893 - 9; PMID: 20353147
   PubMed Web of Science ®Google Scholar
• Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options?. Drugs 2009; 69:1879 - 901; http://dx.doi.org/10.2165/11315690-000000000-00000; PMID: 19747006
   PubMed Web of Science ®Google Scholar
• Spellberg B. The antibiotic crisis: can we reverse 65 years of failed stewardship?. Arch Intern Med 2011; 171:1080 - 1; http://dx.doi.org/10.1001/archinternmed.2011.26; PMID: 21357798
   PubMed Web of Science ®Google Scholar